Are Zucker obese rats a useful model for cardiovascular complications in metabolic syndrome? Physical, biochemical and oxidative stress considerations

Fundamental and Clinical Pharmacology

Volumn 23, Issue 1, 2009, Pages 59-67

  Debin, Régine ^a   Lauzier, Benjamin ^a   Sicard, Pierre ^a   Delemasure, Stéphanie ^a   Amoureux, Sébastien ^a   Duvillard, Laurence ^b   Vergely, Catherine ^a   Cottin, Yves ^a,b   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Coronary reactivity; Electron paramagnetic resonance; Ischemia; Isolated heart; Metabolic syndrome; Zucker rats

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; FREE RADICAL; GLUCOSE; OXYGEN RADICAL; SUPEROXIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY ENDOTHELIUM; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY; GLUCOSE BLOOD LEVEL; HEART; HEART ARRHYTHMIA; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE; IN VITRO STUDY; IN VIVO STUDY; ISOLATED HEART; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; STAINING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WISTAR RAT; ZUCKER RAT;

EID: 61349144912     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2008.00659.x     Document Type: Article

References (32)

1. Alexander C.M., Landsman P.B., Teutsch S.M., Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes (2003) 52 1210 1214.
2. Reinhard W., Holmer S.R., Fischer M. et al. Association of the metabolic syndrome with early coronary disease in families with frequent myocardial infarction. Am. J. Cardiol. (2006) 97 964 967.
3. Zimmet P.Z., Alberti K.G., Shaw J.E. Mainstreaming the metabolic syndrome: a definitive definition. This new definition should assist both researchers and clinicians. Med. J. Aust. (2005) 183 175 176.
4. Lakka H.M., Salonen J.T., Tuomilehto J., Kaplan G.A., Lakka T.A. Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men. Horm. Metab. Res. (2002) 34 492 498.
5. Zeller M., Steg P.G., Ravisy J. et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch. Intern. Med. (2005) 165 1192 1198.
6. Fornoni A., Raij L. Metabolic syndrome and endothelial dysfunction. Curr. Hypertens. Rep. (2005) 7 88 95.
7. Hsueh W.A., Lyon C.J., Quinones M.J. Insulin resistance and the endothelium. Am. J. Med. (2004) 117 109 117.
8. Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. (2004) 24 816 823.
9. Flordellis C.S., Ilias I., Papavassiliou A.G. New therapeutic options for the metabolic syndrome: what's next? Trends Endocrinol. Metab. (2005) 16 254 260.
10. Van Zwieten P.A., Kam K.L., Pijl A.J., Hendriks M.G., Beenen O.H., Pfaffendorf M. Hypertensive diabetic rats in pharmacological studies. Pharmacol. Res. (1996) 33 95 105.
11. Conti M., Renaud I.M., Poirier B. et al. High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2004) 286 793 800.
12. Vincent H.K., Powers S.K., Stewart D.J., Shanely R.A., Demirel H., Naito H. Obesity is associated with increased myocardial oxidative stress. Int. J. Obes. Relat. Metab. Disord. (1999) 23 67 74.
13. Tessier F., Birlouez-Aragon I., Tjani C., Guilland J.C. Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int. J. Vitam. Nutr. Res. (1996) 66 166 170.
14. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic. Biol. Med. (1993) 14 303 311.
15. Vergely C., Maupoil V., Benderitter M., Rochette L. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic. Biol. Med. (1998) 24 470 479.
16. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet (2005) 365 1415 1428.
17. De Gennaro-Colonna V., Rossoni G., Cocchi D., Rigamonti A.E., Berti F., Muller E.E. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats. J. Endocrinol. (2000) 166 529 536.
18. Takeda R., Suzuki E., Satonaka H. et al. Blockade of endogenous cytokines mitigates neointimal formation in obese Zucker rats. Circulation (2005) 111 1398 1406.
19. Toblli J.E., Cao G., DeRosa G., Di Gennaro F., Forcada P. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats. Am. J. Hypertens. (2004) 17 172 180.
20. Wang P., Chatham J.C. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am. J. Physiol. Endocrinol. Metab. (2004) 286 725 736.
21. Fredersdorf S., Thumann C., Ulucan C. et al. Myocardial hypertrophy and enhanced left ventricular contractility in Zucker diabetic fatty rats. Cardiovasc. Pathol. (2004) 13 11 19.
22. Zhou Y.T., Grayburn P., Karim A. et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl Acad. Sci. USA (2000) 97 1784 1789.
23. Svec F., Thompson H., Corll C., Porter J. Levels of hypothalamic neurotransmitters in lean and obese Zucker rats. Nutr. Neurosci. (2002) 5 321 326.
24. Sondergaard S.B., Verdich C., Astrup A., Bratholm P., Christensen N.J. Obese male subjects show increased resting forearm venous plasma noradrenaline concentration but decreased 24-hour sympathetic activity as evaluated by thrombocyte noradrenaline measurements. Int. J. Obes. Relat. Metab. Disord. (1999) 23 810 815.
25. Nishimatsu H., Suzuki E., Satonaka H. et al. Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. (2005) 288 1770 1776.
26. Zhou W., Wang X.L., Kaduce T.L., Spector A.A., Lee H.C. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats. Am. J. Physiol. Heart Circ. Physiol. (2005) 288 2210 2218.
27. Heo Y.R., Claycombe K., Jones B.H. et al. Effects of fatty (fa) allele and high-fat diet on adipose tissue leptin and lipid metabolism. Horm. Metab. Res. (2002) 34 686 690.
28. Millette E., de Champlain J., Lamontagne D. Altered coronary dilation in deoxycorticosterone acetate-salt hypertension. J. Hypertens. (2000) 18 1783 1793.
29. Hoshida S., Yamashita N., Otsu K., Kuzuya T., Hori M. Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. Am. J. Physiol. Heart Circ. Physiol. (2000) 278 256 262.
30. Munzel T., Afanas'ev I.B., Kleschyov A.L., Harrison D.G. Detection of superoxide in vascular tissue. Arterioscler. Thromb. Vasc. Biol. (2002) 22 1761 1768.
31. Oudot A., Martin C., Busseuil D., Vergely C., Demaison L., Rochette L. NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging. Free Radic. Biol. Med. (2006) 40 2214 2222.
32. Sonta T., Inoguchi T., Tsubouchi H. et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic. Biol. Med. (2004) 37 115 123.